RadarScreener › ALLO

ALLO

Allogene Therapeutics, Inc.
Nasdaq · Biological Products, (No Diagnostic Substances) · EDGAR filings (CIK 1737287) · 3 signals · 0 setups · updated Aug 16, 2026

What the filings say Pressure ▼

The company can sell stock into the market any day at prevailing prices — steady supply.

Radar 49 (elevated attention) · dilution pressure elevated · listing risk low · governance risk low · runway 26.7 mo · strongest signal: Shelf filed (Aug 12, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

49Radar · attention score (0–100)
65Dilution pressure · financing + balance sheet
0Listing risk · exchange standards
0Governance risk · reporting, auditor, going concern

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on ALLO
Alerts
One email the morning ALLO files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for ALLO back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 985 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$38.6Mcash + short-term investments as of Jun 30, 2026
26.7 moestimated runway (FY operating cash burn)
$436.2Mstockholders' equity as of Jun 30, 2026
$184.0Mpublic float (10-K cover)
345.5Mshares outstanding as of Aug 10, 2026 · was 243.8M Mar 10, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Aug 12, 2026 Shelf filed S-3 filed 2026-08-12 filing 39
Aug 12, 2026 ATM program “atm” language in S-3 (S-3) filed 2026-08-12 filing 34
Jun 30, 2026 Share count +25% Shares outstanding 243,777,920 (2026-03-10) -> 345,490,881 (2026-08-10), +42% filing 34
Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans